Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Menevit
Active Ingredients: Calcium ascorbate dihydrate 121mg
D-alpha Tocoferol 400IU
Folic acid 500µg
Garlic oil 333µg
Lycopene 6mg
Selenomethionine 4.975mg equivalent to 26µg selenium added as Selenomethionine DCP
Zinc sulfate monohydrate 69.2mg equivalent to 25mg zinc
Dosage Form: Capsule
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Catalent Australia Pty Limited, Braeside, Australia
Product: Panafen Plus
Active Ingredients: Codeine phosphate hemihydrate 12.8mg
Ibuprofen 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Dungarvan Limited, Co. Waterford, Ireland
Dated this 29th day of September 2011.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).